(858) 412-4156

site-logo
  • About
    • Company
    • Technology
    • Business Development
    • Contact
  • Advisor
    • Scientific Advisory Board
  • Pipeline
    • Full Pipeline
    • RBC Nanosponge
      • MRSA Pneumonia
      • MRSA Vaccine
      • Diabetic Foot Ulcer
    • Macrophage Nanosponge
      • Sepsis
      • Cytokine Release Syndrome (CRS)
      • COVID-19
      • Inflammatory Bowel Disease
      • Arthritis
  • News
  • Career
  • Contact
featured-generic.jpg

Investors

Cellics is a pre-clinical biotech company that uses the innovative Nanosponge Technology for a rich product pipeline including infectious diseases, rare and ultra-rare diseases, anti-venom applications, and vaccines. The Nanosponge Technology can also be used for targeted delivery. Cellics has completed Round A financing and will soon start Round B financing.

If you are interested in investing Cellics Therapeutics, please contact us.

Our Mission

Cellics is committed to saving lives and improving patients’ health using innovative biomimetic nanomedicines. We strive to develop more effective and safer therapeutics and vaccines for diseases and unmet medical needs.

Our Info

11588 Sorrento Valley Rd.
Suite #20
San Diego, CA 92121

(858) 412-4156

info@cellics.com


Locate Us

Copyright 2021 © Cellics Therapeutics All rights reserved. Privacy Policy Developed by TinyFrog Technologies